Biogen | BIIB - Créances Commerciales





Créances Commerciales Changement Date
AbbVie USD 12.59B 180M 2025-12
Acadia Pharmaceuticals USD 148.38M 153K 2026-03
ALKERMES USD 407.63M 73.6M 2026-03
Amgen USD 9.14B 432M 2026-03
Bayer EUR 18.55B 4.36B 2026-03
Biogen USD 1.79B 76.6M 2026-03
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
Bristol-Myers Squibb USD 14.36B 164M 2026-03
Eli Lilly USD 21.18B 1.02B 2026-03
Esperion Therapeutics USD 140.19M 21.21M 2025-12
Gilead Sciences USD 4.74B 172M 2026-03
Incyte USD 1.05B 27.09M 2026-03
Merck USD 11.78B 345M 2025-12
Moderna USD 71M 113M 2026-03
Neurocrine Biosciences USD 768.1M 81.3M 2026-03
Novartis USD 9.6B 2.69B 2026-03
Pfizer USD 16.17B 332M 2026-03
PTC Therapeutics USD 181.62M 21.45M 2025-12
Puma Biotechnology USD 28.1M 3.52M 2024-06
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Sangamo BioSciences USD 581K 110K 2024-06
Sanofi EUR 482M 85M 2026-03
Sanofi EUR 482M 85M 2026-03
Sarepta Therapeutics USD 547.91M 149.68M 2026-03
Teva Pharmaceutical Industries USD 3.39B 316M 2026-03
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
United Therapeutics USD 312M 38.2M 2026-03
Vertex Pharmaceuticals USD 2B 56.7M 2026-03